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Abstract IGF-II plays an important role in growth and 
development of vertebrates. In the present study, the character-
ization of the first fish IGF-II gene, chum salmon IGF-II, is 
described. The sIGF-II gene consists of four exons, spanning a 
region of 9 kbp, that encode the 214 aa IGF-II precursor. While 
the amino acid sequences of fully processed IGF-II of salmon and 
mammalian species are very similar, the prepro-peptide sequence 
deviates extensively in the signal- and E-peptide domains. The 
transcription initiation site of the sIGF-II gene was localized 
within a 30 nt region employing RT-PCR. Using sIGF-II 
promoter-luciferase constructs it was demonstrated that the 
sIGF-II gene has a relatively strong promoter that contains 
tissue-specific regulatory elements. 
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1. Introduction 
The insulin-like growth factors (IGF-I and IGF-II) are mi-
togenic peptides that play an important role in the regulation 
of growth and development. The structure of the IGF-II pep-
tide is highly conserved in mammals, birds, and fish (for a 
review see [1]), [2]. The structures of the human, rat, mouse 
and ovine IGF-II genes have been studied in detail (for a 
review see [3]); and all four species show complex patterns 
of IGF-II expression. Heterogeneity of the IGF-II mRNA 
population originates from the use of multiple promoters, 
alternative splicing, and differential use of polyadenylation 
sites. The extensively studied human IGF-II gene comprises 
approximately 30 kbp of genomic DNA and contains nine 
exons. Expression of this gene is regulated in a tissue-specific 
and developmental stage-dependent manner [4]. Transcription 
initiation takes place at exons 1, 4, 5, and 6, which are pre-
ceded by distinct promoters, P1-P4 [4-6]. Promoter PI is ac-
tive exclusively in human adult liver whereas promoters P2-P4 
are active in fetal tissues including the liver and in several 
non-hepatic adult tissues. 
Isolation of rainbow trout {Oncorhynchus mykiss) IGF-II 
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cDNA [7] was a first step towards the characterization of 
the fish IGF-II genes. Analysis of the IGF-II mRNA levels 
in the liver and other tissues of juvenile and adult rainbow 
trout [8] revealed that IGF-II mRNA levels are two-fold high-
er in the adult liver than in the juvenile liver. The growth 
hormone-dependent expression of IGF-II mRNA in the liver 
and pyloric ceca (pancreatic tissue) suggests an important role 
for IGF-II in growth hormone-stimulated growth [9]. In the 
current study we present the nucleotide sequence of the chum 
salmon (Oncorhynchus keta) IGF-II gene as well as the local-
ization of the position of the transcription initiation site and a 
first characterization of the salmon IGF-II promoter. This 
information might be helpful to understand the regulation 
of IGF-II expression and the role of IGF-II 'under water'. 
2. Materials and methods 
2.1. Materials 
Restriction endonucleases, the Klenow fragment of Escherichia coli 
DNA polymerase I, T4 DNA ligase and Taq DNA polymerase were 
purchased from Fermentas (Vilnius, Lithuania) and Boehringer 
Mannheim. Ribonuclease inhibitor (RNasin) and calf intestinal phos-
phatase were from Promega (Madison, WI). Random-primed DNA 
labelling kits were from Boehringer Mannheim and from Amersham 
(Amersham, UK), DNA sequencing kits from United States Biochem-
ical Corporation (Cleveland, OH), [a-32P]dATP and [ex-32P]dCTP 
from Isotope (Tashkent, Uzbekistan), and [a-35S]dATP from Amer-
sham (Amersham, UK). Nylon membranes were from Chemifil (Tal-
linn, Estonia) and GeneScreen membranes from Du Pont de Nemours 
(Dreieich, Germany). Plasmids pBluescript SK+, and pGEM-3Zf(+), 
pGEM-5Zf(+) were from Stratagene (La Jolla, CA) and Promega 
(Madison, WI), respectively. MMLV reverse transcriptase and incu-
bation buffers were from Gibco-BRL (Grand Island, NY). 
2.2. Oligonucleotides and plasmids 
Based on the rainbow trout IGF-II cDNA sequence [7] two primer 
sets specific for various regions of the IGF-II coding region were 
synthesized: (a) 5'-CTGGGAAACTAACTCAACTGCA-3' and 5'-
CCTCTCTGACTTGGCAGGTTT-3' and (b) 5'-TGCGCTGGCAC-
TTACTCTGTA-3' and 5'-CAATTGTGGCTGACGTAGTTGT-3'. 
Employing these primer sets, two coho salmon IGF-II cDNA probes 
were synthesized by RT-PCR using total coho salmon (Oncorhynchus 
kisutch) liver RNA (generously provided by Dr. S. Duguay, Univer-
sity of Washington, USA) as a template. PCR products were purified 
and subcloned in pBluescript SK+, generating clones 5'-D IGF-II 
(425 bp) and Pre-E IGF-II (531 bp), respectively. Promoter fragments 
were cloned into the promoterless firefly luciferase gene containing 
vector pFLASH [10]. In all constructs, the Muni site at position —4 
relative to the first ATG (methionine start codon) of prepro-IGF-II 
was used to link the IGF-II promoter fragments to the Ncol site of 
the luciferase gene (both sites were made blunt-ended by the Klenow 
fragment of DNA polymerase I). Five reporter constructs containing 
promoter fragments of different lengths were obtained: p2100M, 
pl500M, p900M, p500M and p300M (Fig. 3). The longest construct 
(p2100M) was made by cloning a 2.16 kbp long genomic BamHI-
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Muni fragment into the BamHl and Ncol sites of pFLASH. Subse-
quent truncations were made using the appropriate restriction enzyme 
sites at the 5'-end and the blunt-ended Muni and Ncol sites. Because 
of the absence of appropriate restriction sites, the рЗООМ was ob-
tained after treatment with Exonuclease III of a genomic clone and 
the obtained 299 nt fragment was then cloned into pFLASH and 
checked by sequencing. The pFLASH vector without the BamHl-
Ncol polylinker fragment was used as a promoterless control plasmid. 
2.3. Screening of the genomic DNA library and DNA sequence analysis 
Approximately 4X 105 bacteriophage plaques from a chum salmon 
genomic library [11] in XEMBL3 were screened by standard methods 
[12] using the a32P-labeled inserts of clones 5'-D IGF-II or Pre-E 
IGF-II as probes. For DNA nucleotide sequence analysis DNA frag-
ments of plaque-purified positive clones were subcloned in pBluescript 
SK+, pGEM-3Zf(+) and pGEM-5Zf(+) plasmids and were sequenced 
on both strands employing the dideoxynucleotide method with Seque-
nase version 2.0 (USB, Cleveland, OH). 
2.4. Northern blotting and transcription start site determination 
Total RNA was isolated from adult liver of rainbow trout (Onco-
rhynchus mykiss), and chum salmon (Oncorhynchus keta) using the 
single step guanidinium thiocyanate method [13]. RNA (15 μg) was 
glyoxalated and size-separated on a 1% agarose-10 mM sodium phos-
phate gel, and transferred to a GeneScreen membrane. The RNA was 
fixed on the membrane by UV irradiation. Northern blots were hybri-
dized according to GeneScreen protocols with a chum salmon IGF-II 
cDNA probe. The blot was washed to a final stringency of 0.5 X SSC-
1% SDS at 65°C and exposed on Fuji RX X-ray film. 
In order to localize the transcription start site cDNA was synthe-
sized from 1 μg of adult liver coho salmon total RNA with 200 units 
of MMLV reverse transcriptase, and subsequent PCRs were per-
formed in the same tube containing 2.5 units of Taq Polymerase in 
Taq DNA buffer and 0.1 μg of each IGF-II-specific primers as de-
scribed previously [14]. 
2.5. Transient transfection experiments 
The human hepatoma cell line Hep 3B [15] was cultured in a-
modified minimum essential medium (aMEM) and the adenovirus-
transformed kidney cell line 293 [16] was cultured in Dulbecco's modi-
fied Eagle's medium (DMEM). The media were supplemented with 
10% fetal calf serum, 100 IU/ml penicillin, 100 μg/ml streptomycin, 
and 300 μg/ml glutamine. Cells from both cell lines were transfected at 
60% confluence in 25 cm2 flasks using the calcium phosphate copre-
cipitation method [17]. Each flask was transfected with 4.5 μg of a 
promoter-luciferase construct and 0.5 μg of RSV-LacZ which served 
as an internal control for transfection efficiency. Four hours after the 
addition of the precipitate, cells were shocked with 10% dimethylsulf-
oxide in serum-free aMEM or DMEM. Fresh medium was added and 
the cells were harvested after 24 h. Preparation of cell extracts, luci-
ferase assays and ß-galactosidase assays were performed as described 
[12]. Luciferase levels were recorded on a Lumac/3M Biocounter 
M2010A. Luciferin was purchased from Boehringer Mannheim. 
3. Results 
Since previous analysis of members of the Pacific salmon 
family showed a very high degree of homology for the IGF-I 
sequence [18,19], we surmised that the coding sequences of 
IGF-II genes from members of this family would also be 
very similar. Based on this assumption, primers derived 
from the published rainbow trout (Oncorhynchus mykiss) 
IGF-II cDNA sequence [7] were used to synthesize coho sal-
mon (Oncorhynchus kisutch) IGF-II cDNA from adult liver 
mRNA by means of RT-PCR. Two different cDNAs were 
constructed, 5'-D IGF-II and Pre-E IGF-II, which together 
cover the entire coding region of IGF-II. Subsequently, the 
cDNA clone representing the region between the 5'-UTR and 
the D-domain of coho salmon IGF-II was used as a probe to 
screen a chum salmon (Oncorhynchus keta) genomic library 
consisting of approximately 4 x l 0 5 recombinant bacterio-
Fig. 1. Structure and expression of the chum salmon IGF-II gene. 
A: Schematic representation of 17 kbp of contiguous chromosomal 
DNA from the chum salmon IGF-II locus. Exons are depicted by 
boxes, and introns and flanking regions by thin lines. The structure 
of the corresponding mRNA and the domain structure of the sal-
mon prepro-IGF-II peptide are displayed below the gene map. The 
nucleotide sequence data are in GenBank under accession number 
X97225. B: Northern blot analysis of total RNA from adult rain-
bow trout liver (lane 1) and from adult chum salmon liver (lane 2). 
15 μg of total RNA was hybridized with a sIGF-II cDNA probe 
containing the coding sequence. The size of the major IGF-II tran-
script is indicated. Stained ribosomal RNA bands served as size 
markers; for fish 4.1 kbp and 1.85 kbp [23]. 
phages. Two recombinant clones were isolated and character-
ized by restriction endonuclease mapping and Southern blot 
hybridization. One of the positive clones (^sIGFII 1) con-
tained 17 kbp of chum salmon genomic DNA, while the other 
^sIGFII 2) contained 13 kbp of DNA from the same locus. 
Using the two IGF-II cDNA clones as probes, the salmon 
IGF-II locus was analyzed as shown in Fig. 1A. Four differ-
ent exon-containing regions were identified, designated exons 
1^1 (Fig. 1A). All exon-intron boundaries contained canonical 
donor and acceptor splice sequences. 
The chum salmon IGF-II gene locus was subcloned in plas-
mid vectors and the IGF-II gene nucleotide sequence was 
determined. First, the coding sequence of the chum salmon 
gene was compared with that of the isolated coho salmon 
cDNAs. As expected, the coding sequences were completely 
identical with the exception of a silent single nucleotide 
change in the D-domain region. Second, the chum salmon 
gene sequence was compared with the published rainbow 
trout cDNA sequence [7]. Comparison of the 87 nt region 
of the 5'-UTR revealed 3 nt differences, while three nucleotide 
changes were found in the signal peptide sequence, one of 
which led to an amino acid substitution. The IGF-II mature 
peptide encoding sequences of chum salmon and rainbow 
trout contained one silent nucleotide change. In the first 400 
nt of the З'-UTR four deletion/insertions were found and one 
point mutation. 
Mature chum salmon IGF-II is encoded by two exons 
(exons 2 and 3) as in other species (man, mouse, and sheep). 
The leader sequence is located in exons 1 and 2 together 
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encoding a 47 aa long signal peptide with high homology to 
the rainbow trout sequence, but it deviates completely from 
all other known IGF-II leader sequences. The E-domain se-
quences are located in exons 3 and 4 and encode a 97 aa long 
E-peptide, which is conserved between chum salmon and rain-
bow trout but shows only partial homology to the E-peptides 
of IGF-II from other species. 
Since the IGF-II cDNA sequences lack a poly(A) tail, the 
size of the last exon and the precise location of the polyade-
nylation site are unknown. Therefore, assuming that the 5'-
end of the known cDNA [7] was located close to the tran-
scription start site region, we performed Northern blot anal-
ysis to establish the approximate size of the salmon IGF-II 
transcript. Total RNA from adult chum salmon liver and 
adult rainbow trout liver were hybridized with the coho sal-
mon cDNA probe (Fig. IB). A single IGF-II specific mRNA 
band was detected with an approximate size of 4.5 kbp. 
To determine the size of exon 1 and the transcription start 
site of the salmon IGF-II gene, RT-PCR analysis was per-
formed on total RNA from adult liver coho salmon. A single 
reverse primer (Dl) complementary to sequences of exon 2 
and a set of contiguous primers (P1-P5) representing different 
sequences in the putative 5'-flanking/5'-untranslated region 
were used for analysis (Fig. 2A). PCR products of the ex-
pected size were synthesized with the primer pairs D1/P5 
and D1/P4 (Fig. 2B). No products were obtained with the 
primer pairs D1/P3, D1/P2, and Dl/Pl . These results pinpoint 
the sIGF-II transcription start site within a region of approx-
imately 30 nt situated 110-140 nt upstream of first methionine 
codon of sIGF-II (Fig. 2A). 
Finally, to localize the salmon IGF-II promoter and to 
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Fig. 2. Mapping of the sIGF-II transcription start site using RT-
PCR. A: Genomic nucleotide sequence of exon 1 of the chum sal-
mon IGF-II gene. Underlined sequences with numbered arrows rep-
resent the positions of primers P3-P5 used in PCR; primer Dl 
(+906 to +926) in exon 2 served as the reverse primer. Primers PI 
and P2 were located from —670 to —650 and —293 to —273, re-
spectively. The TATA box-like sequence is shown in underlined 
italics. The identified region for the transcription start site location 
is shown in bold. The translation initiation codon is shown in bold 
italics and the A-residue is numbered +1. B: Southern blot analysis 
of the RT-PCR reaction products obtained with forward primers 
P1-P5 and reverse primer Dl. The blot was hybridized with the 5'-
D IGF-II cDNA probe. 
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Fig. 3. Determination of salmon IGF-II promoter activity. Lucifer-
ase activities of the salmon IGF-II gene promoter constructs in Hep 
3B and 293 cell lines. The various sIGF-II promoter-luciferase con-
structs used for the transfections are depicted. Positions are num-
bered relative to the A nucleotide of the first methionine codon of 
sIGF-II (Fig. 2A). The luciferase activity obtained upon transfection 
with the longest p2100M construct was arbitrarily set at 100. Each 
value represents the average of at least three independent, triplicate 
transfection experiments. The standard deviation was within 10% of 
the indicated value. The activity of the promoterless vector alone re-
sulted in values lower than 1% of p2100M. 
analyze its activity we constructed a set of five plasmids con-
taining the putative promoter sequence linked to the luciferase 
reporter gene. The longest sIGF-II promoter-luciferase ex-
pression construct, p2100M, contained an upstream region 
of 2.16 kbp relative to the first methionine codon. Subsequent 
promoter truncation clones were made of which the smallest 
promoter construct, p300M, still contained 160-190 nucleo-
tides upstream of the transcription start site (Fig. 3). Since 
previous studies revealed that the expression of the salmon 
IGF-II gene is regulated in a tissue-specific and developmental 
stage-specific fashion [8], we employed a liver-specific and a 
non-liver-derived cell line (Hep 3B and 293 cells, respectively) 
for transient expression studies of the five salmon IGF-II 
promoter-luciferase expression constructs. All salmon IGF-II 
promoter constructs possess promoter activity. In 293 cells the 
maximal activity was observed with the p2100M and the 
pl500M constructs, and a two-fold decrease was observed 
when the promoter region was truncated from —500 to 
—300. In Hep 3B cells p500M reveals maximal promoter ac-
tivity while additional upstream regions have a negative effect 
on the promoter activity. Truncation of the region from —500 
to —300 results in a 2.4-fold reduction of the promoter activ-
ity in Hep 3B cells. In fact, the promoter is quite strong in 
both cell lines, since the activity of p500M in Hep 3B cells was 
17% of the activity of the human thymidine kinase promoter 
cloned in the pFLASH vector (pTK-Luc) and in 293 cells the 
activity of pl500M is 60% of pTK-Luc (results not shown). 
The activity of the negative control, a promoterless reporter-
luciferase construct, was less than 1% of the activity of the 
salmon promoter constructs. 
Cell type-specific differences in expression of the salmon 
IGF-II promoter constructs in the two cell lines employed 
could be mapped in the region upstream of the p500M con-
struct. The proximal promoter region that is necessary for 
basal transcription is situated within 300 bp upstream of the 
first methionine codon and activating factors might be located 
in the region between —500 and —300. Further analysis of 
these regions is necessary to identify the specific factors that 
may be involved in promoter activation. 
All four known mammalian IGF-II genes have been found 
to form a conserved linkage group with the insulin gene. The 
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IGF-II genes are located downstream of the insulin genes in 
the same transcriptional polarity. In this study we could not 
find linkage of the salmon insulin and IGF-II genes, at least, 
there were no overlapping sequences in 10 kbp of genomic 
sequence 3' to the insulin gene and 5 kbp of genomic sequence 
5' to the IGF-II gene (results not shown). 
4. Discussion 
In this paper we report the isolation and characterization of 
the first fish IGF-II gene. The organization and nucleotide 
sequence of the chum salmon IGF-II gene were determined 
and its promoter was identified. Comparison of IGF-II genes 
from several species which belong to different classes of ani-
mals shows that the overall organization of the IGF-II genes 
is similar. The mature IGF-II protein is encoded by two exons 
(exons 2 and 3 in fish; exons 4 and 5 in rodents; exons 8 and 
9 in sheep; and exons 7 and 8 in man (review [3])) and the 
amino acid sequence of the fully processed IGF-II peptide is 
well conserved. However, as shown in this paper, the sequence 
of the leader exon of the salmon IGF-II gene deviates strongly 
from the known leader exons of the mammalian IGF-II genes. 
While the IGF-II signal peptide in mammals is 24 aa long, the 
salmon signal peptide has a length of 47 aa and shows no 
homology with that of the mammalian species. The salmon 
IGF-II gene is expressed in adult liver tissue yielding a single 
mRNA species of 4.5 kbp as was shown by Northern blotting. 
In addition, it was possible to detect the presence of sIGF-II 
mRNA from the early stages of embryonic development until 
the adult stage using primers for exons 1 and 3 by RT-PCR 
assay (data not shown). This implies that mRNA derived 
from the first exon is present in early embryonic as well as 
adult stages of development and that the corresponding pro-
moter is active in these stages. Since the size of salmon IGF-II 
mRNA is approximately 4.5 kbp, it implies that the salmon 
IGF-II gene, similar to the mammalian IGF-II genes, has a 
very long 3'-UTR. 
The amino acid sequence alignment of IGF-II from mam-
mals, birds, and fish reveals high homology in the B-, A-, and 
D-domains as well as in the first six residues of the E-peptide. 
The C-domain of salmon IGF-II is 3 aa longer than that of 
the mammalian and avian IGF-II. The Lys-X-X-Arg motif at 
the D-domain/E-peptide junction was identified as required 
for processing of proIGF-I [20]. The same motif has been 
conserved in the D-domain/E-peptide junction of all IGF-II 
sequences except for shark IGF-II [1], suggesting that the 
mechanism for IGF-II processing may be similar to that of 
IGF-I. When comparing the IGF-II E-peptides of different 
higher vertebrates it is interesting to note that the salmon 
IGF-II E-peptide contains 97 aa (that is 9 aa longer than 
that of sheep and 8 aa longer than that of other known 
mammalian IGF-II E-peptides). Although the overall se-
quence diverges extensively, several regions of strong homol-
ogy are present in the IGF-II E-peptides. The first region of 
homology is situated at the amino-terminus of the E-peptide 
which is important for the cleavage of proIGF-II to mature 
IGF-II. Pulse-chase experiments have shown that the E-pep-
tide of pro-IGF-II is cleaved at several sites during transport 
through the cell and most steps appear to occur very late in 
the secretory pathway and may also occur extracellularly 
[21]. Conservation of distinct regions in the E-peptide may 
imply a regulated conversion of pro-IGF-II that could be a 
potential mechanism by which its biological activity can be 
modulated. 
A TATA box-like sequence (TATATAATA) was found 157 
bp upstream of the ATG codon encoding the first methionine 
of the signal peptide and 69 bp upstream of the 5'-end of the 
known rainbow trout IGF-II cDNA. Subsequent RT-PCR 
experiments on total salmon liver RNA located the major 
transcription initiation site within a 28 bp long region that 
is situated 111-139 bp upstream of the first methionine codon 
and 10-38 nucleotides downstream of the putative TATA 
box. 
The salmon IGF-II promoter is a relatively strong promoter 
with tissue-specific regulation of expression. Using up to 2 
kbp long sIGF-II promoter-luciferase expression constructs 
it was shown that the basal promoter is contained within 
the first 380^-10 nucleotides upstream of the transcription 
start site, whereas tissue-specific factors may be located up 
to 2 kbp upstream of the transcription start site. Further 
analysis of the specific factors involved in regulation of ex-
pression is required to locate such transcription factors. 
Studies of IGF-II mRNA expression in eight different tis-
sues of both juvenile and adult rainbow trout revealed inter-
esting differences in fish and mammalian IGF-II expression 
[8]. In rainbow trout, IGF-II mRNA is present in both devel-
opmental stages and in all tissues examined. This deviates 
from the mouse and rat expression patterns where IGF-II is 
not expressed after birth, since no adult liver-specific pro-
moter is present [3]. Interestingly, the human IGF-II gene 
does contain a separate promoter that is exclusively activated 
in adult liver tissue [5]. In rainbow trout the level of IGF-II 
mRNA is much higher in adult liver than in juvenile liver. 
This observation could be explained by the fact that the reg-
ulation of IGF-II expression in rainbow trout is growth hor-
mone-dependent in the liver and pyloric ceca [9]. In contrast, 
in the human liver the synthesis of IGF-II is not regulated by 
growth hormone [22]. The high levels of IGF-II in adult liver 
of rainbow trout suggest that salmon, like humans but unlike 
rodents, still express high levels of IGF-II in the adult stage. 
Since only one promoter and a single mRNA species for IGF-
II have been identified in the chum salmon gene, the regula-
tion of expression of IGF-II in adult liver is most likely regu-
lated by a different mechanism in fish than in human adult 
liver. The growth hormone-dependent activation of salmon 
adult liver IGF-II mRNA might be regulated by such a devel-
opmental stage-specific factor. 
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